Sign In
Buy DRIO
$7.50
-0.1000 (-1.32%)
At Close: Jun 05, 2026
Expansion driven by highly successful partnership based on Dario's consistent ability to engage members and deliver scalable value across cardiometabolic conditions NEW YORK, May 26, 2026 /PRNewswire/
DarioHealth Corp. (DRIO) Q1 2026 Earnings Call Transcript
11:40am, Wednesday, 13'th May 2026
DarioHealth Corp. (DRIO) Q1 2026 Earnings Call Transcript
DarioHealth Q1 Earnings Call Highlights
11:06am, Wednesday, 13'th May 2026
DarioHealth NASDAQ: DRIO reported sequential revenue growth for the second straight quarter while outlining plans to expand its digital health platform further into care delivery, management said on t
DarioHealth Corp. (DRIO) Reports Q1 Loss, Beats Revenue Estimates
08:27am, Wednesday, 13'th May 2026
DarioHealth Corp. (DRIO) came out with a quarterly loss of $0.81 per share versus the Zacks Consensus Estimate of a loss of $0.71. This compares to a loss of $1.2 per share a year ago.
DarioHealth Reports First Quarter 2026 Financial and Operating Results
06:30am, Wednesday, 13'th May 2026
First quarter 2026 revenues increased to $5.6 million, marking the second consecutive quarter of sequential growth Operating expenses decreased by 21% year-over-year and decreased by 8% quarter-over-q
DarioHealth to Report First Quarter 2026 Results on Wednesday, May 13, 2026
08:30am, Monday, 04'th May 2026
Company to host conference call and webcast at 8:30 a.m. Eastern Time NEW YORK, May 4, 2026 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital
Findings highlight the role of continuous behavioral support in improving focus, productivity and day-to-day functioning – key priorities for employers and health plans Statistically significant imp
Dario Appoints Veteran Healthcare Executive John R. Palumbo to Board of Directors to Support Accelerated Commercial Scaling
08:00am, Monday, 13'th Apr 2026
Mr. Palumbo's deep relationships across health systems, payers and healthcare's senior executive community expected to accelerate Dario's commercial partnerships and position the Company to realize it
Contrasting DarioHealth (NASDAQ:DRIO) & Thermo Fisher Scientific (NYSE:TMO)
01:10am, Wednesday, 01'st Apr 2026
DarioHealth (NASDAQ: DRIO - Get Free Report) and Thermo Fisher Scientific (NYSE: TMO - Get Free Report) are both medical companies, but which is the better investment? We will compare the two business
DarioHealth Q4 Earnings Call Highlights
01:02am, Saturday, 21'st Mar 2026
DarioHealth (NASDAQ: DRIO) executives highlighted record commercial momentum and continued cost reductions on the company's fourth-quarter and year-end 2025 earnings call, while also addressing the re
DarioHealth Corp. (DRIO) Q4 2025 Earnings Call Transcript
01:22pm, Thursday, 19'th Mar 2026
DarioHealth Corp. (DRIO) Q4 2025 Earnings Call Transcript
DarioHealth Corp. (DRIO) Reports Q4 Loss, Beats Revenue Estimates
08:45am, Thursday, 19'th Mar 2026
DarioHealth Corp. (DRIO) came out with a quarterly loss of $0.8 per share versus the Zacks Consensus Estimate of a loss of $1.57. This compares to earnings of $0.2 per share a year ago.
DarioHealth Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
06:30am, Thursday, 19'th Mar 2026
Fourth quarter 2025 revenues grew sequentially to $5.2 million as compared to $5.0 million in the third quarter of 2025 2025 full-year revenue was $22.4 million, compared to $27.0 million in 2024,
DarioHealth to Report Fourth Quarter and Full Year 2025 Results on Thursday, March 19, 2026
08:30am, Wednesday, 11'th Mar 2026
Company to host conference call and webcast at 8:30 a.m. Eastern Time NEW YORK, March 11, 2026 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digit
Findings reinforce that engagement data provide clinical signals directly impacting ROI Analysis further reveals specific frequency of measurements that drive clinical outcomes and bend the cost curve
